Resources
News, Media, & Presentations
Stay up-to-date with the latest news from across the ElevateBio ecosystem.
Presentations & Publications
// Feb 10, 2026 | Presentation
Advanced Therapies Week 2026
Reducing Turnaround Time and Cost in Cell Therapy Manufacturing Through Integrated At-Line Immunophenotyping QC
// Feb 10, 2026 | Presentation
Advanced Therapies Week 2026
Automating Cell Therapy: A Closed, Digital Platform Delivers Consistent, Sterile, Scalable T‑Cell Production
// Feb 10, 2026 | Presentation
Advanced Therapies Week 2026
Evaluating the Automated Accellix® Platform against Conventional Flow Cytometry for Cell Therapy Samples
// Feb 10, 2026 | Presentation
Advanced Therapies Week 2026
Supporting Therapy Platform Development with Advanced Characterization of Engineered T Cells via Single-cell Sequencing and Flow Cytometry
// Feb 07, 2026 | Presentation
Society for Laboratory Automation and Screening Conference 2026
Precision at any input: High-throughput automated workflow ensures uniform gene expression profiles across broad RNA inputs
// Jan 23, 2026 | Presentation
7th International Conference on Base Editing, Prime Editing & Related Enzymes (Deaminet 2026)
Building a differentiated portfolio of base editors for therapeutic applications
// Jan 22, 2026 | Presentation
7th International Conference on Base Editing, Prime Editing & Related Enzymes (Deaminet 2026)
Engineering potency and specificity of base editors towards genomic medicine
// Oct 07, 2025 | Presentation
2025 Cell & Gene Meeting on the Mesa
Rapid Analytics and Next Generation Sequencing
// Oct 06, 2025 | Presentation
2025 Cell & Gene Meeting on the Mesa
ElevateBio BaseCamp – Delivering Genetic Medicines From Concept Through Commercialization
// Oct 06, 2025 | Presentation
2025 Cell & Gene Meeting on the Mesa
ElevateBio Life Edit – Opening New Frontiers in Genomic Medicine
// Sep 24, 2025 | Presentation
CAR-TCR Summit
Successfully Implementing Lean Manufacturing for Late Phase and Commercial CGT
// Sep 24, 2025 | Presentation
CAR-TCR Summit
Non-Viral TCR Knock-In Using LEG14 Nuclease and HDR Templates for T-Cell Engineering
// Sep 16, 2025 | Poster
BioProcess International Conference
Streamlining CRISPR-Cas9 gene editing with LipidBrick® Cell Ready
// Jul 22, 2025 | Presentation
5th mRNA-Based Therapeutics Summit 2025
In Vivo Investigation of RNA Optimization Strategies for Maximizing Gene Editing in the Liver
// Jun 12, 2025 | Presentation
CASSS CGTP Summit Rockville, MD
Optimizing Analytical Release Testing Through Reduced Volume and Turnaround Times
// Jun 11, 2025 | Presentation
CASSS CGTP Summit Rockville, MD
Advanced Sequencing Approaches for Comprehensive AAV Vector Characterization
// Jun 02, 2025 | Presentation
Cell & Gene Therapy Talk Framingham, MA
A Novel Approach to Treating Huntington’s Disease Using AAV to Deliver Gene Editing Tools to the Brain
// May 17, 2025 | Presentation
American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting New Orleans, LA
Advancing Lentiviral Vector Manufacturing: A Platform for Commercial Cell Therapy Success
// May 17, 2025 | Presentation
American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting New Orleans, LA
Broad Biodistribution and Expression of Allele Selective LETI-101 in Critical Brain Regions for Treatment of Huntington’s Disease Following Intrastriatal Delivery in NHP
// May 15, 2025 | Poster
American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting New Orleans, LA
Deep CRISPR Nuclease Portfolio and Multiple Editing Modalities Accelerates Identification of Viable Clinical Candidates
// May 15, 2025 | Poster
American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting New Orleans, LA
Peripheral Blood Mononuclear Cell (PBMC) Isolation Using Cell Fractionation Filters
// May 14, 2025 | Poster
American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting New Orleans, LA
Signature of Base Editor RNA Edits in the Transcriptome and Reduction of Exogenous RNA Editing
// May 13, 2025 | Poster
American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting New Orleans, LA
Electroporation and Lipid Nanoparticles as Delivery Methods for Targeted CRISPR/Cas9 Gene Editing in Primary Human T-Cells
// May 07, 2025 | Poster
International Society for Cell & Gene Therapy New Orleans, LA
Evaluating Buoyancy Activated Cell Sorting (BACS) for T cell Isolation in CAR-T Manufacturing
// Apr 07, 2025 | Presentation
CRISPR Medicines 2025 Conference Copenhagen, DK
Harnessing a diverse collection of CRISPR-associated RNA-guided nucleases and a proprietary nonviral delivery platform for precise gene editing
// Feb 25, 2025 | Presentation
20th Annual Huntington's Disease Therapeutics Conference Palm Springs, CA
AAV5-delivered Life Edit® CRISPR system results in broad CNS biodistribution and allele selective editing and reduction of mHTT protein in critical HD brain regions
// Feb 02, 2025 | Presentation
3rd Viral Vector Process Development & Manufacturing Summit Boston, MA
Novel Approach to Treating Rare Disease Using an AAV Vector to Deliver Gene Editing Tools to the Brain
// Jan 31, 2025 | Presentation
5th Annual Summit of Biologics Conference and Workshop on Biopharmaceutical Product Development Goa, India
Potency Development for Cell & Gene Therapy Products
// Jan 21, 2025 | Presentation
Phacilitate Advanced Therapies Week Dallas, Texas
Driving Innovation and Scalability In Advanced Therapies
// Nov 07, 2024 | Presentation
31st Annual Meeting of the Huntington Study Group Cincinnati, OH
Allele-selective editing of mHTT utilizing AAV5-delivered Life Edit®️ CRISPR System (LETI-101) results in meaningful reduction of mHTT protein
// Oct 24, 2024 | Presentation
Outsourced Pharma Capacity Update
How to Navigate the Successful Transition from Clinical to Commercial Manufacturing in Cell Therapy
// Oct 16, 2024 | Presentation
Formulation & Delivery U.S. 2024 Conference San Diego, CA
Enabling In Vivo Gene Editing with Proprietary Lipid Nanoparticles (LNPs)
// September 23-26, 2024 | Presentation
BioProcess International 2024 Boston, MA
Generation, Characterization, and Stability of iPSC Lines
// September 23-26, 2024 | Presentation
Cell and Gene Therapy International 2024 Boston, MA
Viral Design: Impact of Early Integration Across R&D and Process Development Workflows to Accelerate Development
// September 23-26, 2024 | Presentation
Cell and Gene Therapy International 2024 Boston, MA
Analytical Capabilities at ElevateBio BaseCamp Utilizing LentiPeak™
// September 17-20, 2024 | Poster
9th Annual CAR-TCR Summit Boston, MA
From Clinical Success to Commercial Readiness
// August 19-22, 2024 | Poster
16TH Annual Bioprocessing Summit Boston, MA
Rapid Development of Ion Exchange Chromatography for Full/Empty Separation in Adeno-Associated Virus Serotype 5
// August 19-22, 2024 | Poster
16TH Annual Bioprocessing Summit Boston, MA
Evaluation of Alternative Process Cell Lysis Reagents as Replacements for Triton X-100 for AAV Production
// Jul 25, 2024 | Presentation
Outsourced Pharma Capacity Update
LentiPeak™️ Plug and Play Capabilities for a Lentiviral Vector Platform Process
// Jul 09, 2024 | Presentation
Global Cell & Gene Therapy Summit Boston, MA
Low Volume Wash, Formulation and Fill Strategies for T Cell Therapies
// Jun 13, 2024 | Presentation
CASSS Cell & Gene Therapy Products Symposium 2024 Rockville, MD
Balancing Flexibility and Standardization of AAV Manufacturing Processes
// Jun 12, 2024 | Presentation
CASSS Cell & Gene Therapy Products Symposium 2024 Rockville, MD
Potency Development for an In Vivo AAV Gene Editing Therapy
// May 2024 | Presentation
Outsourced Pharma
Phase Appropriate Potency Strategy Using Analytical Capabilities at BaseCamp
// May 10, 2024 | Poster
American Society of Gene and Cell Therapy’s (ASGCT) 27th Annual Meeting Baltimore, MD
Development and Scale Up of a Robust End-to-End Manufacturing Process for High Quality AAV Production
// May 10, 2024 | Poster
American Society of Gene and Cell Therapy’s (ASGCT) 27th Annual Meeting Baltimore, MD
A Rapid and Scalable 96-Well Platform to Screen CARs and TCRs
// May 10, 2024 | Poster
American Society of Gene and Cell Therapy’s (ASGCT) 27th Annual Meeting Baltimore, MD
Early Characterization of Research-Grade AAV6 Productions Allows for Manufacturing Alignment During Candidate Nomination
// May 10, 2024 | Poster
American Society of Gene and Cell Therapy’s (ASGCT) 27th Annual Meeting Baltimore, MD
Design and Production of Circular RNAs (circRNAs) with Validated Functional Activity in Cell Models
// Feb 26, 2024 | Poster
CHDI’s 19th Annual Huntington’s Disease Therapeutics Conference Palm Springs, CA
Allele Selective SNP Editing Utilizing AAV5-delivered Life Edit® Nuclease and guide RNA Resulting in Meaningful Reduction of mutant HTT Protein
// Oct 12, 2023 | Presentation
Cell & Gene Therapy Manufacturing & Commercialization US Conference Boston, MA
Charting a Resilient Path Forward: Future Proofing the Cell and Gene Therapy Supply Chain
// Oct 06, 2023 | Presentation
Cell & Gene with Outsourced Pharma - Virtual Webinar
ElevateBio Capacity Update October 2023
// Sep 20, 2023 | Poster
Cell & Gene Therapy Manufacturing & Commercialization US Conference Boston, MA
Optimization of Nuclease Treatment for Removal of Residual DNAs in Adeno-Associated Viruses
// Sep 08, 2023 | Poster
International Society for Cell & Gene Therapy Houston, TX
Development of a Proprietary HEK293 Suspension Cell Line for Robust rAAV and LVV Production
// Aug 17, 2023 | Poster
Genome Engineering: CRISPR Frontiers Conference Cold Spring Harbor, NY
Utilizing PAM diversity for allele-specific knockdown of mut-HTT in vivo
// Aug 16, 2023 | Poster
15th Annual Bioprocessing Summit Boston, MA
Development and Optimization of a Scalable Affinity Purification of Adeno Associated Virus Serotype 6
// May 19, 2023 | Poster
The American Society of Gene and Cell Therapy’s (ASGCT) 26th Annual Meeting
Optimization of Nuclease Digestion Unit Operation in a Lentiviral Vector Process for Increased Reduction of DNA Impurities
// May 19, 2023 | Poster
The American Society of Gene and Cell Therapy’s (ASGCT) 26th Annual Meeting
Promoter Triage & PRE Triage for Gene Expression & Function Optimization
// May 18, 2023 | Poster
The American Society of Gene and Cell Therapy’s (ASGCT) 26th Annual Meeting
A Robust and Scalable Research Grade Platform Process for AAV6 Production and Purification
// May 17, 2023 | Poster
The American Society of Gene and Cell Therapy’s (ASGCT) 26th Annual Meeting
Upstream Optimization Paved a Straightforward Path for High Percentage of Full Capsids in AAV6
// Apr 25, 2023 | Presentation
18th Annual Huntington's Disease Therapeutics Conference Dubrovnik, Croatia
Allele-selective SNP editing utilizing AAV5-delivered Life Edit® nuclease and guide RNA resulting in meaningful reduction of mutant HTT protein
// Apr 25, 2023 | Poster
18th Annual Huntington's Disease Therapeutics Conference Dubrovnik, Croatia
Mutant and wildtype huntingtin protein quantitation utilizing automated capillary electrophoresis
// Apr 25, 2023 | Poster
18th Annual Huntington's Disease Therapeutics Conference Dubrovnik, Croatia
Allele Selective SNP Editing Utilizing AAV5-delivered Life Edit® Nuclease and guide RNA Resulting in Meaningful Reduction of mutant HTT Protein
// Sep 27, 2022 | Poster
BioProcess International
A Scalable and Robust Lentiviral Platform for GMP Manufacturing
// Jun 12, 2022 | Poster
CRISPR 2022
Compact RNA-guided nucleases from nonpathogenic soil microbes provide new tools for efficient and robust editing in human cells
// May 03, 2022 | Poster
The American Society of Gene & Cell Therapy (ASGCT)
A Robust and Scalable Platform Process for GMP Manufacturing of Lentiviral Vectors
Whitepapers
